Beetham Thomas W. is Chief Operating Officer of Viridian Therapeutics Inc.
Person profile
Roles
Viridian Therapeutics
Chief Operating Officer
Dianthus Therapeutics
Officer
Address
Hamilton, Bermuda
Employees
SEC CIK
Latest filings (excl ownership)
No filings
Latest ownership filings
3
Viridian Therapeutics, Inc.\DE
1 Nov 23
4
Viridian Therapeutics, Inc.\DE
1 Nov 23
4
Magenta Therapeutics, Inc.
2 Dec 22
4
Magenta Therapeutics, Inc.
1 Aug 22
4
Magenta Therapeutics, Inc.
6 Jun 22
4
Magenta Therapeutics, Inc.
19 May 22
4
Magenta Therapeutics, Inc.
17 Feb 22
4
Magenta Therapeutics, Inc.
20 Sep 21
4
Magenta Therapeutics, Inc.
16 Sep 21
4
Magenta Therapeutics, Inc.
15 Jun 21
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
30 Oct 23 | VRDN Viridian Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 13.02 | 474,400 | 6.18 mm | 474,400 |
30 Nov 22 | DNTH Dianthus Therapeutics | Common Stock | Grant | Acquire A | No | No | 0.94 | 3,000 | 2.82 k | 19,897 |